Neurocrine Biosciences



Ebit تغيير تاريخ
AbbVie USD 5.72B 69M 2025-06
Acadia Pharmaceuticals USD 32.37M 13.08M 2025-06
Agios Pharmaceuticals USD -127056000 20.43M 2025-06
ALKERMES USD 92.98M 79.19M 2025-06
Alnylam Pharmaceuticals USD 4.89M 13.19M 2025-06
Amgen USD 2.26B 1.34B 2025-06
Biogen USD 816.6M 233.8M 2025-06
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Cytokinetics USD -111506000 44.12M 2025-06
Dynavax Technologies USD 10.86M 34.49M 2025-06
Exelixis USD 215.68M 28.82M 2025-07
Gilead Sciences USD 2.7B 189M 2025-06
Halozyme Therapeutics USD 202.44M 54.09M 2025-06
Incyte USD 310.82M 27.18M 2025-06
Ionis Pharmaceuticals USD 144.78M 290.78M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
Pfizer USD 2.6B 3.33B 2025-06
Prothena USD -64897000 1.62M 2024-12
Regeneron Pharmaceuticals USD 1.52B 608.6M 2025-06
Repligen USD 5.96M 17.45M 2025-06
Sarepta Therapeutics USD 115.58M 415.96M 2025-06
Teva Pharmaceutical Industries USD 406M 540M 2025-06
Ultragenyx Pharmaceutical USD -193567000 50.63M 2025-06
Vertex Pharmaceuticals USD 1.15B 420.8M 2025-06


Neurocrine Biosciences - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.